國立虎尾科技大學 |

How to Overcome the Antibiotic Crisis = Facts, Challenges, Technologies and Future Perspectives /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	How to Overcome the Antibiotic Crisis / edited by Marc Stadler, Petra Dersch.
其他題名:	Facts, Challenges, Technologies and Future Perspectives /
其他作者:	Stadler, Marc.
面頁冊數:	XII, 496 p.online resource. :
Contained By:	Springer Nature eBook
標題:	Medical microbiology. -
電子資源:	https://doi.org/10.1007/978-3-319-49284-1
ISBN:	9783319492841

How to Overcome the Antibiotic Crisis = Facts, Challenges, Technologies and Future Perspectives /
How to Overcome the Antibiotic Crisis Facts, Challenges, Technologies and Future Perspectives /[electronic resource] :edited by Marc Stadler, Petra Dersch. - 1st ed. 2016. - XII, 496 p.online resource. - Current Topics in Microbiology and Immunology,3980070-217X ;. - Current Topics in Microbiology and Immunology,387.

Tackling threats and future problems of multidrug-resistant bacteria.-Emergence and spread of antimicrobial resistance: recent insights from bacterial population genomics -- Epidemiology of Staphylococcus aureus nasal carriage patterns in the community -- Diagnostics and resistance profiling of bacterial pathogens -- Use of antibiotics and antimicrobial resistance in veterinary medicine as exemplified by the swine pathogen Streptococcus suis.-Antibiotics and the intestinal microbiome: individual responses, resilience of the ecosystem and the susceptibility to infections -- Anti-virulence strategies to target bacterial infections -- Strategies to block bacterial pathogenesis by interference with motility and chemotaxis -- New horizons in the development of novel needle-free immunization strategies to increase vaccination efficacy -- History of antibiotics research -- Actinobacteria and Myxobacteria – Two of the most important bacterial resources for novel antibiotics -- Exploitation of fungal biodiversity for discovery of novel antibiotics -- Strategies for the discovery and development of new antibiotics from natural products: Three Case Studies -- New structural templates for clinically validated and novel targets in antimicrobial drug research and development -- Synthesis of antibiotics -- Antibiotics clinical development and pipeline -- Anti-infectives in drug delivery—overcoming the Gram-negative bacterial cell envelope.

This volume focuses on antibiotics research, a field of topical significance for human health due to the worrying increase of nosocomial infections caused by multi-resistant bacteria. It covers several basic aspects, such as the evolution of antibiotic resistance and the influence of antibiotics on the gut microbiota, and addresses the search for novel pathogenicity blockers as well as historical aspects of antibiotics. Further topics include applied aspects, such as drug discovery based on biodiversity and genome mining, optimization of lead structures by medicinal chemistry, total synthesis and drug delivery technologies. Moreover, the development of vaccines as a valid alternative therapeutic approach is outlined, while the importance of epidemiological studies on important bacterial pathogens, the problems arising from the excessive use of antibiotics in animal breeding, and the development of innovative technologies for diagnosing the “bad bugs” are discussed in detail. Accordingly, the book will appeal to researchers and clinicians alike.

ISBN: 9783319492841

Standard No.: 10.1007/978-3-319-49284-1doiSubjects--Topical Terms:

583124
Medical microbiology.

LC Class. No.: QR46

Dewey Class. No.: 616.9041

How to Overcome the Antibiotic Crisis = Facts, Challenges, Technologies and Future Perspectives /
LDR:03993nam a22004095i 4500 001 977907
003 DE-He213
005 20200705063129.0
007 cr nn 008mamaa
008 201211s2016 gw | s |||| 0|eng d
020 $a 9783319492841 $9 978-3-319-49284-1
024 7 $a 10.1007/978-3-319-49284-1 $2 doi
035 $a 978-3-319-49284-1
050 4 $a QR46
072 7 $a MMFM $2 bicssc
072 7 $a MED052000 $2 bisacsh
072 7 $a MKFM $2 thema
082 0 4 $a 616.9041 $2 23
245 1 0 $a How to Overcome the Antibiotic Crisis $h [electronic resource] : $b Facts, Challenges, Technologies and Future Perspectives / $c edited by Marc Stadler, Petra Dersch.
250 $a 1st ed. 2016.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a XII, 496 p. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Current Topics in Microbiology and Immunology, $x 0070-217X ; $v 398
505 0 $a Tackling threats and future problems of multidrug-resistant bacteria.-Emergence and spread of antimicrobial resistance: recent insights from bacterial population genomics -- Epidemiology of Staphylococcus aureus nasal carriage patterns in the community -- Diagnostics and resistance profiling of bacterial pathogens -- Use of antibiotics and antimicrobial resistance in veterinary medicine as exemplified by the swine pathogen Streptococcus suis.-Antibiotics and the intestinal microbiome: individual responses, resilience of the ecosystem and the susceptibility to infections -- Anti-virulence strategies to target bacterial infections -- Strategies to block bacterial pathogenesis by interference with motility and chemotaxis -- New horizons in the development of novel needle-free immunization strategies to increase vaccination efficacy -- History of antibiotics research -- Actinobacteria and Myxobacteria – Two of the most important bacterial resources for novel antibiotics -- Exploitation of fungal biodiversity for discovery of novel antibiotics -- Strategies for the discovery and development of new antibiotics from natural products: Three Case Studies -- New structural templates for clinically validated and novel targets in antimicrobial drug research and development -- Synthesis of antibiotics -- Antibiotics clinical development and pipeline -- Anti-infectives in drug delivery—overcoming the Gram-negative bacterial cell envelope.
520 $a This volume focuses on antibiotics research, a field of topical significance for human health due to the worrying increase of nosocomial infections caused by multi-resistant bacteria. It covers several basic aspects, such as the evolution of antibiotic resistance and the influence of antibiotics on the gut microbiota, and addresses the search for novel pathogenicity blockers as well as historical aspects of antibiotics. Further topics include applied aspects, such as drug discovery based on biodiversity and genome mining, optimization of lead structures by medicinal chemistry, total synthesis and drug delivery technologies. Moreover, the development of vaccines as a valid alternative therapeutic approach is outlined, while the importance of epidemiological studies on important bacterial pathogens, the problems arising from the excessive use of antibiotics in animal breeding, and the development of innovative technologies for diagnosing the “bad bugs” are discussed in detail. Accordingly, the book will appeal to researchers and clinicians alike.
650 0 $a Medical microbiology. $3 583124
650 0 $a Infectious diseases. $3 1102043
650 0 $a Bacteriology. $3 668505
650 0 $a Pharmacology. $3 583819
650 0 $a Medicinal chemistry. $3 1253747
650 0 $a Veterinary medicine. $3 785002
650 1 4 $a Medical Microbiology. $3 668401
650 2 4 $a Infectious Diseases. $3 668393
650 2 4 $a Pharmacology/Toxicology. $3 593882
650 2 4 $a Medicinal Chemistry. $3 668872
650 2 4 $a Veterinary Medicine/Veterinary Science. $3 1114372
700 1 $a Stadler, Marc. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1116189
700 1 $a Dersch, Petra. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1116190
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319492827
776 0 8 $i Printed edition: $z 9783319492834
776 0 8 $i Printed edition: $z 9783319841212
830 0 $a Current Topics in Microbiology and Immunology, $x 0070-217X ; $v 387 $3 1254330
856 4 0 $u https://doi.org/10.1007/978-3-319-49284-1
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)